Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jia Huang, Yun Wang, Jun Chen, Yanlei Zhang, Zheng Yuan, Li Yue, Josep Maria Haro, Maria Victoria Moneta, Diego Novick & Yiru Fang. (2018) Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline. Neuropsychiatric Disease and Treatment 14, pages 2473-2484.
Read now
Read now
Diego Novick, William Montgomery, Ellen Vorstenbosch, Maria Victoria Moneta, Héctor Dueñas & Josep Maria Haro. (2017) Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study. Patient Preference and Adherence 11, pages 1859-1868.
Read now
Read now
Diego Novick, William Montgomery, Josep Maria Haro, Maria Victoria Moneta, Gang Zhu, Li Yue, Jihyung Hong, Héctor Dueñas & Roberto Brugnoli. (2016) Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia. Neuropsychiatric Disease and Treatment 12, pages 383-392.
Read now
Read now
Jihyung Hong, Diego Novick, William Montgomery, Maria Victoria Moneta, Héctor Dueñas, Xiaomei Peng & Josep Maria Haro. (2015) Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting. Patient Preference and Adherence 9, pages 1481-1490.
Read now
Read now
Diego Novick, Jihyung Hong, William Montgomery, Héctor Dueñas, Magdy Gado & Josep Maria Haro. (2015) Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study. Neuropsychiatric Disease and Treatment 11, pages 197-205.
Read now
Read now
Anita H Clayton, Saria El Haddad, Josepha-Pearl Iluonakhamhe, Caridad Ponce Martinez & Alexandra Elizabeth Schuck. (2014) Sexual dysfunction associated with major depressive disorder and antidepressant treatment. Expert Opinion on Drug Safety 13:10, pages 1361-1374.
Read now
Read now
Articles from other publishers (21)
Gerd Laux & Ansgar Klimke. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
27
.
Gerd Laux & Ansgar Klimke. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1319
1345
.
James Brockbank, Taryn Krause, Emily Moss, Anne Milthers Pedersen, Michael Frank Mørup, Outi Ahdesmäki, Jake Vaughan & Thor-Henrik Brodtkorb. (2021) Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review. Health and Quality of Life Outcomes 19:1.
Crossref
Crossref
Hesham Y Elnazer & David S Baldwin. (2020) Structured review of the use of the Arizona sexual experiences scale in clinical settings. Human Psychopharmacology: Clinical and Experimental 35:3.
Crossref
Crossref
Angel Montejo, Nieves Prieto, Rubén de Alarcón, Nerea Casado-Espada, Javier de la Iglesia & Laura Montejo. (2019) Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach. Journal of Clinical Medicine 8:10, pages 1640.
Crossref
Crossref
Angel L. Montejo, Joemir Becker, Gloria Bueno, Raquel Fernández-Ovejero, María T. Gallego, Nerea González, Adrián Juanes, Laura Montejo, Antonio Pérez-Urdániz, Nieves Prieto & José L. Villegas. (2019) Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic Study. Journal of Clinical Medicine 8:5, pages 719.
Crossref
Crossref
Angel L. Montejo, Julia Calama, Fernando Rico-Villademoros, Laura Montejo, Nerea González-García & Jesús Pérez. (2019) A Real-World Study on Antidepressant-Associated Sexual Dysfunction in 2144 Outpatients: The SALSEX I Study. Archives of Sexual Behavior 48:3, pages 923-933.
Crossref
Crossref
Julie Islin, Cecilie Hurup Munkboel & Bjarne Styrishave. (2018) Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay. Toxicology in Vitro 47, pages 63-71.
Crossref
Crossref
Mira Aubuchon & Erma Z. Drobnis. 2018. Bioenvironmental Issues Affecting Men's Reproductive and Sexual Health. Bioenvironmental Issues Affecting Men's Reproductive and Sexual Health
221
241
.
Carmita Helena Najjar Abdo. 2018. Sexual Dysfunctions in Mentally Ill Patients. Sexual Dysfunctions in Mentally Ill Patients
225
249
.
Jihyung Hong, Diego Novick, Maria Victoria Moneta, Ahmed El-Shafei, Héctor Dueñas & Josep Maria Haro. (2017) Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East. Clinical Practice & Epidemiology in Mental Health 13:1, pages 145-155.
Crossref
Crossref
Erma Z. Drobnis & Ajay K. NangiaErma Z. Drobnis & Ajay K. Nangia. 2017. Impacts of Medications on Male Fertility. Impacts of Medications on Male Fertility
63
101
.
Alejandro Szmulewicz, Cecilia Samamé, Pablo Caravotta, Diego J. Martino, Ana Igoa, Diego Hidalgo-Mazzei, Francesc Colom & Sergio A. Strejilevich. (2016) Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications. International Journal of Bipolar Disorders 4:1.
Crossref
Crossref
G. Lucy Wilkening, Shelly A. Kucherer & Antoine B. Douaihy. (2016) Priapism and renal colic in a patient treated with duloxetine. Mental Health Clinician 6:4, pages 197-200.
Crossref
Crossref
R Garg. (2016) Role of Duloxetine as Adjuvant in Chemotherapy Induced Peripheral Neuropathic Pain-An Update. Journal of Addiction Medicine and Therapeutic Science, pages 010-012.
Crossref
Crossref
Jihyung Hong, Diego Novick, William Montgomery, Maria Victoria Moneta, Héctor Dueñas, Xiaomei Peng & Josep Maria Haro. (2015)
Real‐world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in
E
ast
A
sia
. Asia-Pacific Psychiatry 8:1, pages 51-59.
Crossref
Crossref
Jihyung Hong, Diego Novick, William Montgomery, Jaume Aguado, Héctor Dueñas, Xiaomei Peng & Josep Maria Haro. (2015) Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?. Clinical Practice & Epidemiology in Mental Health 11:1, pages 130-139.
Crossref
Crossref
Rajnish Mago, Rajeev Mahajan & Dileep Borra. (2014) Antidepressant-Induced Sexual Dysfunction: an Updated Review. Current Sexual Health Reports 6:3, pages 177-183.
Crossref
Crossref
Jeffrey M. Witkin, Michael A. Statnick, Linda M. Rorick-Kehn, John E. Pintar, Michael Ansonoff, Yanyun Chen, R. Craig Tucker & Roberto Ciccocioppo. (2014) The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacology & Therapeutics 141:3, pages 283-299.
Crossref
Crossref
Ursula Reichenpfader, Gerald Gartlehner, Laura C. Morgan, Amy Greenblatt, Barbara Nussbaumer, Richard A. Hansen, Megan Van Noord, Linda Lux & Bradley N. Gaynes. (2013) Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis. Drug Safety 37:1, pages 19-31.
Crossref
Crossref
Levent Alev, Alan Lenox-Smith, Murat Altin & Héctor Dueñas. (2013) A Review of the Serotonin-Norepinephrine Reuptake Inhibitors: Pharmacologic Aspects and Clinical Implications for Treatment of Major Depressive Disorder and Associated Painful Physical Symptoms. Open Journal of Depression 02:04, pages 54-63.
Crossref
Crossref